Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$0.34 - $1.0 $26,337 - $77,463
-77,463 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$0.96 - $1.62 $17,139 - $28,923
-17,854 Reduced 18.73%
77,463 $74,000
Q2 2021

Aug 16, 2021

BUY
$1.09 - $1.49 $103,895 - $142,022
95,317 New
95,317 $133,000
Q3 2020

Nov 13, 2020

SELL
$0.87 - $2.08 $32,856 - $78,553
-37,766 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$1.08 - $4.0 $40,787 - $151,064
37,766 New
37,766 $58,000

Others Institutions Holding CWBR

# of Institutions
1
Shares Held
1.14K
Call Options Held
0
Put Options Held
0

About CohBar, Inc.


  • Ticker CWBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,906,940
  • Market Cap $1.48M
  • Description
  • CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...
More about CWBR
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.